“Accuracy is key” could easily be the motto of NYU Langone Respiratory Screening Center. This center stands as a testament to New York City’s rapid response to health crises. It is a place where cutting-edge technology meets dedicated medical expertise.
NYU Langone Respiratory Screening Center played a vital role during the COVID-19 pandemic. In spring of 2020, hospitals faced agonizing delays of up to two weeks for test results. NYU Langone swiftly changed this narrative.
On March 13, 2020, the FDA authorized a new coronavirus test. NYU Langone became one of only two academic medical centers in New York City equipped to process it. A team led by Dr. Maria E. Aguero-Rosenfeld worked tirelessly to validate the system. By Monday morning, NYU Langone was ready to launch its high-volume COVID-19 testing center.
Housed in a converted bike room near the Ronald O. Perelman Center for Emergency Services, the center began processing hundreds of samples daily. Results were available within 24 hours. This rapid turnaround was a game changer for clinical care. Dean and CEO Robert I. Grossman hailed the launch as “an extraordinary effort.”
Soon, similar sites opened at NYU Langone Hospital–Brooklyn and NYU Langone Hospital–Long Island. Together, these facilities conducted up to 2,400 tests a day. By the end of July 2020, the total count exceeded 140,000 tests.
NYU Langone prioritized accuracy above all else. Dr. Joan F. Cangiarella emphasized that they refused to compromise on test quality. The center used advanced systems like the Roche cobas 6800 and the Cepheid GeneXpert. These systems could detect even tiny amounts of the virus. This sensitivity ensured that even asymptomatic carriers tested positive.
The team overcame many challenges. When shortages of reagents and nasal swabs threatened to halt testing, they found creative solutions. NYU Langone procured swabs from non-COVID-19 test kits. The Office of Science and Research followed a recipe for creating their own solution to protect the integrity of samples.
Volunteers played a crucial role. Hundreds stepped up. Their enthusiasm was truly impressive despite the contagious disease. NYU Langone continues to innovate in testing capabilities. They rolled out a 3-in-1 test for RSV, flu, and COVID-19. A rapid saliva test for COVID-19 is also under consideration.
NYU Langone’s commitment to innovation extends beyond COVID-19. The Lung Cancer Screening Program uses state-of-the-art CT scans for early detection. Experts guide patients through every step. This includes screening, diagnosis, and treatment. NYU Langone has been a pioneer in lung cancer screening since 2000. They participate in national research networks. They adhere to high-quality standards.
So, the next time you’re near NYU Langone Respiratory Screening Center, remember its story. Remember the dedication, innovation, and unwavering commitment to accuracy that define this vital institution.